Wordt geladen...
Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation
In thrombolytic therapy, plasminogen activators (PAs) are still the only group of drug approved to induce thrombolysis, and therefore, critical for treatment of arterial thromboembolism, such as stroke, in the acute phase. Functionalized nanocomposites have attracted great attention in achieving tar...
Bewaard in:
| Gepubliceerd in: | Molecules |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766944/ https://ncbi.nlm.nih.gov/pubmed/31546842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24183407 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|